Search company, investor...
Onkos Surgical company logo

Onkos Surgical

Founded Year



Series C - III | Alive

Total Raised


Last Raised

$4M | 5 mos ago

About Onkos Surgical

Onkos Surgical is a specialty medtech company dedicated to advancing surgical oncology solutions. Onkos Surgical is developing products for both hard and soft-tissue applications. The company was founded in 2015 and is based in Parsippany, New Jersey.

Headquarters Location

77 East Halsey Road

Parsippany, New Jersey, 07054,

United States


Missing: Onkos Surgical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

ESPs containing Onkos Surgical

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Life Sciences / Medical Devices Tech

This market looks at the use of 3D-printed technology to develop organs and tissues to be utilized in surgical procedures. These companies are addressing the often urgent need for having these types of items readily available to maintain patients' health.

Onkos Surgical named as Highflier among 9 other companies, including Aspect Biosystems, Prellis Biologics, and 4D Biomaterials.

Missing: Onkos Surgical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Onkos Surgical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Onkos Surgical is included in 3 Expert Collections, including Medical Devices.


Medical Devices

11,883 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Health IT

7,901 items

Onkos Surgical Patents

Onkos Surgical has filed 1 patent.

The 3 most popular patent topics include:

  • Implants (medicine)
  • Prosthetics
  • Orthopedic surgical procedures
patents chart

Application Date

Grant Date


Related Topics




Orthopedic surgical procedures, Implants (medicine), Prosthetics, Soft tissue disorders, Soft tissue


Application Date


Grant Date



Related Topics

Orthopedic surgical procedures, Implants (medicine), Prosthetics, Soft tissue disorders, Soft tissue



Latest Onkos Surgical News

Global Limb/Leg Lengthening Surgery Market Size to grow USD 8.6 Billion by 2030 | CAGR of 8.7%

Nov 2, 2022

GlobeNewswire The Global Limb/Leg Lengthening Surgery Market Size was valued at USD 4.1 billion in 2021 and the worldwide limb/leg lengthening surgery market share is expected to reach USD 8.6 billion by 2030. Companies Covered: DePuy, Sonova Holding, Johnson & Johnson, Onkos Surgical, NuVasive, Zimmer, Smith & Nephew, Wright Medical, Stryker Corp and Major Key Players from Worldwide. New York, United States , Nov. 02, 2022 (GLOBE NEWSWIRE) -- According to a research report published by Spherical Insights & Consulting, the Global Limb/Leg Lengthening Surgery Market Size to grow from USD 4.1 billion in 2021 to USD 8.6 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period. The expansion of the cosmetics business has led to a greater emphasis placed on physical appearance and aesthetics, which has increased the number of individuals choosing to have cosmetic surgery worldwide. A rising number of people are turning to cosmetic surgery for various reasons, one of which is how movies and social media have shifted people's ideas about what constitutes attractiveness. Asia Pacific is expected to grow the fastest during the forecast period followed by North America & Europe. AD Get a Sample PDF Brochure: The COVID-19 pandemic has made an adverse impact on credit portfolios. There has been an unprecedented rise in unemployment and disruption in economic activity, putting a strain on the solvency of customers and companies. Central banks have taken a proactive approach by injecting liquidity into the market by lowering interest rates and asset purchase programs. Managing and monitoring credit, market, liquidity, and operational risk across financial markets were hard enough with ongoing geopolitical tensions, international trade wars, and the occasional hurricanes and earthquakes. The current pandemic situation has forced chief risk officers and their teams to recalibrate old assumptions and models used to manage and monitor risk. COVID-19s global impact has shown that interconnectedness plays an important role in international cooperation. As a result, many governments started rushing toward identifying, evaluating, and procuring reliable solutions powered by AI. The Lengthening Over Nail segment accounts for the largest market size during the forecast period Based on the procedure, the Limb/Leg lengthening surgery market is categorized into Lengthening Over Nail, Prostheses, and External Fixation. The Lengthening Over Nail segment accounts for the largest market size during the forecast period. It is anticipated that the lengthening over nail procedure sector would increase at a respectable pace over the forecast period. The expansion of treatment options for lower-limb length disparities may be responsible for the increase that has taken place. Because of these novel treatment choices, the risk of developing problems during bone lengthening procedures has been significantly reduced. The objective of the process known as bone length regeneration is to make the limbs of a person measure the same length. This contributes to an improvement in the aesthetic as well as the practical look, which is what is driving the expansion of the market. AD The ambulatory surgical centers segment to hold a higher CAGR during the forecast period Based on end user, the Limb/Leg lengthening surgery market is categorized into Ambulatory Surgical Centers, Specialty Clinics, and Others. The Ambulatory surgical centers segment to hold higher CAGR during the forecast period. Because of expanding public health awareness as well as government measures to promote ambulatory healthcare services, the number of people receiving treatment as outpatients has expanded dramatically in recent years. The expansion of ambulatory surgery centers may be attributed to a number of factors, including an ageing population that is growing in number, an increase in the incidence of chronic diseases, a rise in the cost of medical treatment, and technological developments. The expansion of this market segment is being driven by the provision of more complex surgical procedures at these centers, along with shorter hospital stays for patients. Browse key industry insights spread across 198 pages with 104 market data tables and figures & charts from the report " Global Limb/Leg Lengthening Surgery Market Size , Share, and COVID-19 Impact Analysis, By Procedure (Lengthening Over Nail, Prostheses, and External Fixation), By End User (Ambulatory Surgical Centers, Specialty Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 2030. in detail along with the table of contents Buy Now Full Report: North America to hold a higher CAGR during the forecast period. The Global Limb/Leg lengthening surgery Market has been segmented into five major regions: Asia-Pacific, Europe, APAC, Latin America, and MEA. North America is estimated to account for the highest market share in 2022. This is due to the increasing spending capacity of people in North America for improvements to their aesthetics and the increasing adoption of cosmetic and limb-lengthening surgery in North America. Another factor contributing to the expansion of the limb or leg lengthening surgery market in North America is the presence of highly developed medical facilities and infrastructure in the area. AD Inquire Before Buying This Research Report: Key Companies & Recent Developments: The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Companies Covered: DePuy, Sonova Holding, Johnson & Johnson, Onkos Surgical, NuVasive, Zimmer, Smith & Nephew, Wright Medical, Stryker Corp and Major Key Players from Worldwide. Browse Related Reports Global Artificial Tendons and Ligaments Market Size, Share & Trends, COVID-19 Impact Analysis Report, By Implant Type (Silastic-rod implant, Marlex mesh, Carbon-Fibre implant, Others), By Application (Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries, Spine Injuries, Hip Injuries, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Others): By Region Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021-2030 Global Diabetic Retinopathy Market Size, Share, Study Analysis, By Type (Proliferative Diabetic Retinopathy, Diabetic Macular Edema (DME)), By Treatment Type (Anti VEGF Drug, Steroid Implants, Laser Surgeries, And Vitrectomy), By End User (Hospitals, Ophthalmic Centres, Ambulatory Surgery Centres, Others); By Region Global Insights, Growth, Size, Comparative Analysis, Trends And Forecast, 2021-2030 Global Lentiviral Vectors Market Size, Share, and COVID-19 Impact Analysis, By Component (Lentiviral promoter, Lentiviral fusion tags, Lentivirus packaging systems and Other), By Type (Product and Services), By Generation (4th-generation, 3rd-generation, 2nd-generation and 1st-generation), By Workflow (Upstream Processing And Downstream Processing), By Delivery Method (In Vivo and Ex Vivo), By Disease Indication (Cancer, Genetic Disorders, Infectious Diseases, Veterinary Disease And Other), By Application (Gene Therapy And Vaccinology), By End User (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Contract Development and Manufacturing Organization (CDMO) and Academic/Research Institutes), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2021 2030. AD

Onkos Surgical Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Onkos Surgical Rank

Onkos Surgical Frequently Asked Questions (FAQ)

  • When was Onkos Surgical founded?

    Onkos Surgical was founded in 2015.

  • Where is Onkos Surgical's headquarters?

    Onkos Surgical's headquarters is located at 77 East Halsey Road, Parsippany.

  • What is Onkos Surgical's latest funding round?

    Onkos Surgical's latest funding round is Series C - III.

  • How much did Onkos Surgical raise?

    Onkos Surgical raised a total of $65.33M.

  • Who are the investors of Onkos Surgical?

    Investors of Onkos Surgical include 1315 Capital, Canaan Partners, MedTech Innovator and 3D Systems Ventures.

  • Who are Onkos Surgical's competitors?

    Competitors of Onkos Surgical include Stratasys, restor3d, Kumovis, Neo, Centinel Spine, Vertos Medical, Markforged, Formlabs, Nexa3D, Cyfuse Biomedical and 22 more.

Compare Onkos Surgical to Competitors

Carbon Logo

Carbon is a 3D printing company that works at the intersection of hardware, software, and molecular science. Its SpeedCell is a system of connected manufacturing unit operations that enables repeatable production of end-use parts with industrial-grade materials. It caters mainly to the automotive, consumer, industrial life sciences, and dental industries. The company was founded in 2013 and is based in Redwood City, California.


Paragon28 creates new and improved solutions to the challenges faced by foot and ankle specialists.

Formlabs Logo

Formlabs designs and manufactures 3D printing systems for engineers, designers, and artists.

Cyfuse Biomedical

Cyfuse Biomedical is focused on the development, manufacturing, and sales of regenerative medicine-related products. The company aims to contribute to the medical fields of regenerative medicine and drug discovery by generating steric tissues and organs. The company has developed Regenova, a 3D bioprinter.

Vertos Medical

Vertos Medical is a medical device company committed to developing minimally invasive treatments for lumbar spinal stenosis (LSS). Its proprietary technologies include mild®, which offers a safe, outpatient, minimally invasive, fluoroscopically guided therapeutic LSS treatment that requires no general anesthesia, no implants, and no stitches. LSS is primarily a degenerative, age-related narrowing of the lower spinal canal that causes symptoms of pain and numbness in the lower back, legs, or buttocks. mild® treats this condition by restoring space in the spinal canal using specialized mild® devices to remove hypertrophic ligamentum flavum through a 5.1 mm treatment portal. Clinical trials show that mild® can help LSS patients stand longer and walk farther with less pain1, and no major device-related complications have been reported.2


HeyGears is a manufacturer of advanced industrial 3D printers. Its printers are capable of printing medical grade equipment.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.